HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions

Epilepsia

Volumn 51, Issue 2, 2010, Pages 297-300

  Ikeda, Hiroko ^a   Takahashi, Yukitoshi ^a,b   Yamazaki, Etsuko ^a   Fujiwara, Tateki ^a   Kaniwa, Nahoko ^c   Saito, Yoshiro ^c   Aihara, Michiko ^c   Kashiwagi, Mariko ^d   Muramatsu, Masaaki ^d  

^a SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Carbamazepine; Cutaneous adverse drug reactions; HLA class I; HLA B*5901; Stevens Johnson syndrome

Indexed keywords

CARBAMAZEPINE; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHINESE; CLINICAL ARTICLE; DISEASE SEVERITY; DRESS SYNDROME; EPILEPSY; FEMALE; GENE FREQUENCY; GENETIC MARKER; HAPLOTYPE; HUMAN; JAPAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; RISK FACTOR; SCHOOL CHILD; SKIN TOXICITY; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

ADOLESCENT; ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARBAMAZEPINE; CHILD; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; EPILEPSY; FEMALE; GENE FREQUENCY; GENETIC MARKERS; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-B ANTIGENS; HUMANS; INFANT; MALE; MIDDLE AGED; PHARMACOGENETICS; RISK FACTORS; STEVENS-JOHNSON SYNDROME;

EID: 75649107833     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02269.x     Document Type: Article

References (11)

1. Chung WH, Hung HS, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT. (2004) Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428:486.
2. Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, Lin YL, Lan JL, Yang LC, Hong HS, Chen MJ, Lai PC, Wu MS, Chu CY, Wang KH, Chen CH, Fann CS, Wu JY, Chen YT. (2005) HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U.S.A. 15:4134-4139.
3. Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, Hu SL, Wu MT, Chen GS, Wong TW, Hsiao PF, Shih HY, Fang WH, Wei CY, Lou YH, Lin JJ, Chen YT. (2006) Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics 16:297-306.
4. Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Sawada J, Furuya H, Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R; JSAR research group. (2008) HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 9:1617-1622.
5. Kashiwagi M, Aihara M, Takahashi Y, Yamazaki E, Yamane Y, Yixuan S, Muramatsu M, Ikezawa Z. (2008) HLA genotypes in carbamaze-pine-induced severe cutaneous adverse drug response in Japanese patients. J Dermatol 10:683-685.
6. Locharernkul C, Loplumlert J, Limotai C, Korkij W, Desudchi T, Tongkobpetch S, Kangwanshiratada O, Hirankarn N, Suphapeetiporn K, Shotelersuk V. (2008) Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia 49:2087-2091.
7. Marsh SGE, Parham P, Barber LD. (2000) The HLA facts book. Academic Press, London.
8. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F, Mockenhaupt M, Paoletti C, Shapiro S, Shear N, Schöpf E, Kaufman DW. (1995) Medication use and the risk of Stevens-Johnson syndrome or toxic syndrome or toxic epidermal necrolysis. N Engl J Med 333:1600-1607.
9. Saag M, Balu R, Phillips E, Brachman P, Martorell C, Burman W, Stancil B, Mosteller M, Brothers C, Wannamaker P, Hughes A, Sutherland-Phillips D, Mallal S, Shaefer M. (2008) Study of Hypersensitivity to Abacavir and Pharmacogenetic Evaluation Study Team. High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. Clin Infect Dis 1:1111-1118.
10. Takahashi Y. (2007) Study of HLA in patients of severe cutaneous reaction by AEDs and controls. In Kaniwa N (Eds) Report of investigation about diagnosis, treatment and genetic markers in severe cutaneous reaction (H18-002). Ministry of Health, Labor and Welfare, Tokyo, pp. 33-35.
11. Ueta M, Tokunaga K, Sotozono C, Inatomi T, Yabe T, Matsushita M, Mitsuishi Y, Kinoshita S. (2008) HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese. Mol Vis 14:550-555.